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Abstract
Background: Most ordinary differential equation (ODE) based modeling studies in systems biology involve a
hold-out validation step for model validation. In this framework a pre-determined part of the data is used as validation
data and, therefore it is not used for estimating the parameters of the model. The model is assumed to be validated if
the model predictions on the validation dataset show good agreement with the data. Model selection between
alternative model structures can also be performed in the same setting, based on the predictive power of the model
structures on the validation dataset. However, drawbacks associated with this approach are usually under-estimated.
Results: We have carried out simulations by using a recently published High Osmolarity Glycerol (HOG) pathway
from S.cerevisiae to demonstrate these drawbacks. We have shown that it is very important how the data is partitioned
and which part of the data is used for validation purposes. The hold-out validation strategy leads to biased
conclusions, since it can lead to different validation and selection decisions when different partitioning schemes are
used. Furthermore, finding sensible partitioning schemes that would lead to reliable decisions are heavily dependent
on the biology and unknown model parameters which turns the problem into a paradox. This brings the need for
alternative validation approaches that offer flexible partitioning of the data. For this purpose, we have introduced a
stratified random cross-validation (SRCV) approach that successfully overcomes these limitations.
Conclusions: SRCV leads to more stable decisions for both validation and selection which are not biased by
underlying biological phenomena. Furthermore, it is less dependent on the specific noise realization in the data.
Therefore, it proves to be a promising alternative to the standard hold-out validation strategy.
Keywords: Kinetic models, ODE, Differential equations, Model validation, Model selection, Cross validation, Hold-out
validation
Background
Ordinary differential equation (ODE) based kinetic mod-
els are able to capture all of the available kinetic infor-
mation regarding a biological system. Therefore, they are
used extensively in systems biology especially for the pur-
pose of predicting time dependent profiles and steady
state levels of biochemical species in conditions where
experimental data is not available. Examples from the
literature show that there is a common path taken by
the modeling community for the construction and the
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analysis of ODE based systems biology models. The first
step is to define the model structure and the associated
kinetics. Due to serious concerns about the validity of
model structures and kinetics, many studies include the
parallel development and analysis of multiple alternative
model structures [1–3]. The second step is the estimation
of the unknown model parameters by fitting the model to
the data using global and local minimization algorithms.
Data here are usually in vivo time series concentration
data of the observable biochemical species included in the
model. At this step, uncertainty in the estimated values of
the model parameters can also be quantified by construct-
ing confidence intervals [4–6]. Last but not least, models
are assessed for the quality of their fit to the data and for
their predictive power on independent data. Independent
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data are datasets that were not used for parameter estima-
tion. Selection between alternative model structures can
also be performed at this step. A complete modeling cycle
includes all these steps to achieve sufficiently goodmodels
[7, 8].
A good model has to be sufficient both in explaining the
data on which it was built and in predicting independent
data [9]. The first is taken into account mostly by likeli-
hood ratio tests which can be used to reject models based
on the quality of fit to the data [10–13]. The second aspect
has been considered in conceptually two different ways.
The first approach uses a penalized likelihood based met-
ric such as Akaike’s (AIC) [14] or Bayesian Information
Criterion (BIC) [15]. This metric is calculated using the
whole dataset for parameter estimation but provides an
expected value of the prediction error on an independent
dataset. Therefore, it makes selecting the true complexity
of a model possible because unnecessarily complex mod-
els are poor in predicting independent datasets. However,
it is an ‘in-sample’ measure whichmeans that the expected
prediction error is valid only for the exact same experi-
mental conditions as of the parameter estimation dataset
[10]. Predicting the kinetics of the biological system under
different experimental conditions is the very purpose of
kinetic models, though. Therefore, modelers would like to
show that the newly built model is good in qualitative or
quantitative prediction of experimental data that was col-
lected at different experimental conditions. This strategy
which uses data at different experimental conditions as
validation data constitutes the second approach to assess
the prediction error [8, 16].
Different experimental conditions are usually based on
the following scenarios:
• Inhibition of enzymes.
• Reduction of protein levels by RNAi mediated
suppression.
• Gene deletions.
• Over-expression of genes in gene networks.
• Dose-response experiments in which different doses
of triggering chemicals are used to stimulate the
system.
These validation scenarios are popularly applied since
the common goal of the modelers is to demonstrate
the models’ competency under challenging conditions.
Estimating the parameters of a model in certain exper-
imental conditions and showing their competency in
other conditions within these scenarios requires multi-
ple datasets under different conditions and, therefore, it
is an example to the hold-out validation strategy. That
is, a pre-determined set of conditions are held out of the
training data and used as validation data instead. How-
ever, rules about the application of this strategy are not
straightforward.
There are potential pitfalls associated with the appli-
cation of hold-out validation strategies in the validation
and selection of kinetic systems biology models. These
arise due to the lack of a satisfying answer to the ques-
tion: which part of the dataset should be held out of the
parameter estimation and instead should be used as the
validation dataset?We carried out simulations to demon-
strate the phenomena that hinder us from giving satisfac-
tory answers to this question which can also be referred
to as the problem of selecting an appropriate hold-out
partitioning scheme for the data. The problem arises due
to incomplete biological knowledge of the system and
unknown true values of themodel parameters. Thismakes
the problem a paradoxical one since our knowledge about
the system will never be complete and the true values of
the model parameters are themselves what we are look-
ing for. However, statistics literature offers an established
method which is independent of this knowledge, namely
cross-validation.
Cross-validation (CV) is a resamplingmethod tradition-
ally used for model selection, determining the optimal
complexity of a model or assessment of its generalizabil-
ity in statistics [17, 18]. It is based on the partitioning of
the data in training and test sets. The training set is used
to build the model and the predictions of the model on
the test set are used for model assessment. Since the test
set is completely independent of the parameter estimation
process, selection will not be biased towards more com-
plicated models. The efficiency of cross-validation and its
difference from hold-out validation strategy lies in the fact
that the partitioning is made not in a pre-determined but
in a random way and the procedure is repeated multiple
times so that each partition can be used as test set at least
once. Different variants of CV exist such as leave-one-out,
k-fold and stratified k-fold cross-validation. A compre-
hensive evaluation and comparison of these methods can
be found in [19–21] for classifier selection and in [22] for
the selection of regression models.
CV has been applied in different ways in the ODE based
modeling framework. Partitions can consist of different
experiments (such as different cell types, experimental
conditions or cultures), data belonging to different bio-
chemical species in the same experiment or different data
points within the time profile of the same biochemical
species. In [23], the authors present an example for the lat-
ter. In this work, prediction errors on test sets obtained
by using an ODE based model are compared to the resid-
uals from an unsupervised data analysis method which
does not make any use of biochemical knowledge. Bet-
ter predictions found by using the unsupervised principal
components analysis (PCA) method give hints on the
low informative level of the ODE model leading to a
rejection of the proposed ODE model structure. CV by
using different species from the same or different cultures
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with different experimental conditions was considered by
[24]. In that study, prediction errors were used to select
not between two single models but between two fami-
lies of models each constituted of models with slightly
different topologies. Both approaches use a k-fold strati-
fied partitioning scheme in which time points or species
were approximately equally distributed between k differ-
ent partitions. The prediction errors from different test
sets are averaged for the final measure of the predictive
power.
Existence of only very few examples like we mentioned
above show that CV has been highly neglected in the
field. Also, the risks associated with the hold-out valida-
tion strategy have been underestimated. The conceptual
differences between the two methods and the difference
between their outcomes have not been presented in detail.
Therefore, with this paper we aim to present a detailed
comparison of the hold-out and cross-validation methods
by using simulations and emphasize the advantages of CV
over hold-out partitioning schemes. More details on our
implementation of CV are given in the Methods section.
The reason for choosing simulations for our demonstra-
tive purposes is that simulations and synthetic data allows
us to know the ground truth, in this case the true model
parameters and the true model structure. Therefore, we
can analyze the results we achieved in different partition-
ing schemes in a comparative manner. We mainly look at
the effect of different partitioning schemes in the outcome
ofmodel validation and selection. However, we report also
results related to its effect on parameter estimation which
is very influential on validation and selection in order to
present a complete explanation.
Methods
Simulated data
We used the high osmolarity glycerol pathway model in
S.cerevisiae which was presented as the best approximat-
ing model in [25] (see Fig. 1) to generate synthetic data.
The model is available in Biomodels Database [26] with
the accession number MODEL1209110001. The readers
are referred to the original paper for the details of the
model structure.
The pathway can be triggered by using an NaCl shock
and is activated via two parallel upstream signaling routes.
The activity of the upstream routes is encoded by a binary
input parameter which indicates that the route is either
active or not. The level of the NaCl shock is also an
input parameter which can be manipulated. Therefore,
the model can be used also for deletion mutants where
only one of the signaling routes is active, following dif-
ferent doses of NaCl shock, by changing only those two
input parameters. It includes additional 20 free parame-
ters which can be estimated from data.
We mimicked the real experimental conditions used
in [25] when generating the data. These include differ-
ent cell types and different NaCl doses. The different cell
types were deletion mutants in which only the signaling
branch through Sln1 activation or Sho1 activation was
active and the wild type cell in which both branches were
active (Fig. 1). The different NaCl shock levels ranged
between 0.07 and 0.8 M (Fig. 2). The data consisted
mainly of the ratio of the active phosphorylated Hog1 pro-
tein to the maximum Hog1 protein level observed in the
wild type cell which was expressed as a percentage. The
Hog1 protein phosphorylation percentage data (Hog1PP
data) from 3 cell types and 6 doses formed 18 different
subsets of Hog1PP data. We used different subsets for
parameter estimation andmodel validation/selection each
time within different data partitioning schemes which we
explain in detail in the following section. Concentration
data of other species in the model were essential for the
estimation of the parameters downstream from the Hog1
protein. For this reason, measurements of mRNA, pro-
tein and glycerol levels at 0.5 M. NaCl shock were always
a part of the training dataset. Therefore, the terms ’vali-
dation data’ and ’training data’ refer only to Hog1PP data,
throughout the text.
We generated 100 different realizations of synthetic data
by adding error to the time profiles obtained by themodel.
We added heterogeneous noise where the noise term for
each concentration value was drawn from a normal dis-
tribution with a standard deviation equal to 10% of the
concentration value itself which reflects realistic noise lev-
els and structure for these type of experiments. The time




In this work, we evaluate the performance of the hold-out
validation partitioning schemes based on two most popu-
larly applied challenge scenarios: gene deletions and dose-
response experiments. The first scenario in our study
mimics a gene deletion challenge. In each scheme of this
scenario (Fig. 3), the training set is composed of all six
doses of a single cell type. All six doses of the other two
cell types can be used as validation data. The outcomes
of model validation and selection are determined based
on each of these twelve different subsets of validation
data, separately. The schemes are named throughout the
manuscript as Sln1, Sho1 and WT schemes depending on
the cell type used for training.
Our second scenariomimics the dose-response strategy.
In this scenario, the training set is composed of one dose
from each cell type. In the lowest dose scheme, only the
data following a 0.07 M. NaCl shock are used for train-
ing (Fig. 4). In the highest dose scheme, only the data
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Fig. 1 The pathway topology proposed in [25]. We used this model as our true model and generated data based upon it. The black lines with small
arrow tips depict the transition between different species in the model like production, degradation or complex formation. The black lines with
open circle tips depict the phosphorylation process by kinases. The lines with open triangle tips show activating regulatory interactions whereas
lines with blunt ends show deactivating regulatory interactions. The red colored double arrow denotes the post translational regulation of glycerol
production by the active phosphorylated Hog1 protein. We did not consider this regulatory interaction in our simplified model. The dotted ellipses
in the upper left hand corner indicate the two different upstream activation routes important in our study. Parts of the pathway whose parameters
were affected by the choice of the partitioning scheme were highlighted yellow and gray. We explained the changes in the parameters of those
regions in our results section. (Figure adopted from [23])
following a 0.8 M. NaCl shock are used for training. The
remaining five doses from each cell type can be used as
validation data. Similar to the first scenario, the outcomes
of model validation and selection are determined based on
each of these fifteen subsets of validation data, separately.
Lastly, we introduce variation in the training sets. We
update our first scenario in such a way that in each parti-
tioning scheme (Fig. 5a-c), we use data from two cell types
for training. All six doses from the remaining cell type
can be used as validation data. We make consensus deci-
sions on model validation and selection considering all
the validation subsets. The schemes are named through-
out the manuscript as Sln1/Sho1, Sln1/WT and Sho1/WT
schemes depending on the pair of training cell types. We
update our second scenario in such a way that in each
partitioning scheme (Fig. 5d-e), we use either data from
the four highest or four lowest doses from each cell type
for training. The remaining two doses from each cell type
can be used as validation data. Similar to the first updated
scenario we make consensus decisions using all validation
subsets at once. The schemes are named as low doses and
high doses schemes based on the doses used in the train-
ing set. This way, we can obtain five schemes (Fig. 5) each
of which uses twelve subsets of the phosphorylated Hog1
(Hog1PP) data for training and the remaining six sub-
sets for validation. Therefore, these five schemes can be
compared to the stratified cross-validation scheme which
also makes use of twelve subsets of Hog1PP data in each
training set.
Stratified random cross-validation scheme
In a random cross-validation scheme, there are no
pre-defined partitions, unlike the hold-out partition-
ing schemes. Here, we implement stratified random
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Fig. 2 Experimental conditions under which the data was generated. Check marks indicate the measurements that were performed. Each row
shows a different dose in a different cell type whereas columns are for different biochemical species measured. Hog1PP data consists of 18 subsets
(6 different doses and 3 different cell types) and is the main subject of variability between different partitioning schemes that we evaluated
cross-validation which is a specific type of cross-
validation in which the training sets can be forced to
follow a certain structure. We randomly partition the data
into training and validation sets, in three different runs.
In each run, we force the training sets to include the same
amount of data from each cell type and dose level. We
estimate the parameters and also calculate the measures
we that we use for the analysis of the simulations (fur-
ther explained in the next subsection), at each run. Later,
we make consensus decisions using the average of these
measures that were evaluated at each run. The different
partitioning schemes applied in each run can be seen in
Fig. 6.
Stratified cross-validation is based on the idea of pro-
viding training sets in which all classes of data are repre-
sented approximately equally. In our case, different classes
of data are different cell types and different doses. This
makes it a suitable scheme for our purposes, because we
anticipate biased parameter estimates and hence, biased
model validation and selection when training sets are
dominated by certain classes of data. A stratified scheme
would typically avoid such a problem and would givemore
robust results across different runs of cross-validation
compared to other cross-validation approaches.
Parameter estimation
For each partitioning scheme, we estimated the parame-
ters of both the true model (the model that we accepted
as the ground truth and generated the data upon that) and
the simplified model (the model that lacked one of the
important regulatory interactions in the true model which
Hasdemir et al. BMC Systems Biology  (2015) 9:32 Page 6 of 19
Fig. 3 Scenario 1 partitioning schemes. Light gray colored boxes show parts of the data which we used as the training set (T) for parameter
estimation. Dark gray colored boxes show parts which we used as validation sets (V). Different background colors represent different partitioning
schemes and are consistent with the colors used in the graphs in the Results and discussion section. Each partitioning scheme offered the use of six
subsets of the Hog1PP data as the training set and the remaining twelve subsets of the Hog1PP data could be used for validation, separately. The
training set included either (a) Sln1 data, (b) Sho1 data or (c) WT data
can be seen in Fig. 1). We repeated the parameter esti-
mation process by using 100 different realizations of the
data. The estimation of the parameters required the min-
imization of the difference between the data and model
predictions. We carried out the minimization using the
local minimizer ‘lsqnonlin’ function of Matlab [27, 28].
We considered a local optimizer to be sufficient since we
work with generated data and could use the true values of
parameters as starting points.
In the case of real data, true values of the parameters
are not known. However, usually there is prior informa-
tion on the ranges of the values that the parameters can
take. In such a situation, uniformly distributed random
starting points can be generated in these ranges and opti-
mization with lower and upper bounds can be performed
starting from the different initial points, aiming to find
the same minimum in a sufficient number of runs. We
took this approach for a single example noise realization.
We assumed that the parameter ranges span intervals that
are twice as big as the true values of the parameters.
We started the optimization from 80 different starting
points and could achieve the same minimum with the
one achieved when the true values of the parameters were
used as the starting point, in 20% of the runs. The cor-
relation between the parameter estimate vectors of these
runs was above 0.99. This finding confirmed that per-
forming parameter estimation in a more realistic setting
does not affect the minimum achieved if there is good
prior information on the parameter ranges. Therefore, we
use fixed starting points (true values of the parameters)
throughout the study due to its substantial advantage in
computational power.
Measures used for the analysis of the simulations
We analyzed five main features from the simulations,
namely the amount of bias in the parameter estimates,
the predictive power of the models on the validation
datasets, the number of wrong decisions in which the sim-
plified model structure was selected over the true model
structure and the distance between the predicted profiles
by the true and the simplified model structures (model
separation).
We use normalized bias (nBi) as a measure of the bias in
each estimated parameter (Equation 1). The median of its
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Fig. 4 Scenario 2 partitioning schemes. Light gray colored boxes show parts of the data which we used as the training set (T) for parameter
estimation. Dark gray colored boxes show parts which we used as validation sets (V). Different background colors represent different partitioning
schemes and are consistent with the colors used in the graphs in the Results and discussion section. Each partitioning scheme offered the use of
three subsets of the Hog1PP data as the training set. These are the lowest dose subset of each cell type in the lowest dose scheme and the highest
of each in the highest dose scheme. The remaining fifteen subsets of the Hog1PP data could be used for validation, separately. These are the lowest
dose subset of each cell type in (a) the lowest dose scheme and the highest of each in (b) the highest dose scheme
distribution across different noise realizations gives us the







i = 1:20 index for parameters in the model
j = 1:100 index for noise realizations (1)
We use normalized standard deviation of parameter
estimates as a measure of identifiability levels of parame-
ters. We obtain the standard deviation of the estimates by
calculating the Fisher Information Matrix.
We quantify the lack of good predictive power of models
by using percentage errors. Percentage error is the per-
centage of the sum of squares of the prediction error to
the sum of squares of validation data (Equation 2). Model
selection between the two models gives wrong results
when PET > PES, meaning that the simplified model gives














i = 1:I index for validation subsets of Hog1PP data
j = 1:15 index for time points
I = total number of Hog1PP subsets used for validation
(2)
The difference between the true and the simplified
model predictions (TS) can be calculated by using the
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Fig. 5 Partitioning schemes used in the adapted scenarios. Light gray colored boxes show parts of the data which we used as the training set (T) for
parameter estimation. Dark gray colored boxes show parts which we used as the validation set (V). Different background colors represent different
partitioning schemes and are consistent with the colors used in the graphs in the Results and discussion section. Each partitioning scheme offers the
use of twelve subsets of the Hog1PP data as the training set and the remaining six subsets as the validation set. The training set included either (a)
Sln1 & Sho1 data, (b) Sln1 &WT data, (c) Sho1 &WT data, (d) the lowest four doses from each cell type or (e) the highest four doses from each cell type
trapezoidal rule as in Equation 3. With this method, the
area between two curves can be approximated as a series
of trapezoids (see Fig. 7). The sum of the areas of the trape-
zoids provide a good approximation of the area between
the curves when the number of trapezoids are sufficiently
high. Here, the two curves are the profiles of the Hog1PP
predicted by the true and the simplified model structures.
We normalize the calculated area with respect to the
maximum of the Hog1PP data in the corresponding vali-
dation subset. Large areas between the two curves mean
that the separation of the two model structures is eas-
ier. Therefore, when correct model selection decisions
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Fig. 6 Stratified random cross-validation scheme (SRCV). Light gray colored boxes show parts of the data which we used as training sets (T) for
parameter estimation. Dark gray colored boxes show parts which we used as validation sets (V). In each of the three runs, the training and the
validation sets change as indicated in these graphs
are given, model separation (TS) can be used as an

















T: numerical values of the Hog1PP predictions by the
true model structure
S: numerical values of the Hog1PP predictions by the
simplified model structure
k = 1:K-1 index for trapezoids
i = 1:I index for validation subsets of Hog1PP data
j = 1:15 index for time points
I = total number of validation subsets
(3)
Results and discussion
Scenario 1: partitioning of data from different cell types
Firstly, we would like to stress that in all of our simulations,
we observed very good fit of the true model structure to
the data. Additionally, our emphasis in this work is on
model validation and selection using validation datasets
which were excluded from the training set. Therefore, we
do not present detailed analysis of the quality of model
fits. Only in Fig. 8 and Additional file 1: Figure S2, we
present the model fits together with the predictions in two
Fig. 7 Trapezoidal Rule. The figure explains the trapezoidal rule
visually. The green shaded area refers to the area of the (k − 1)th
trapezoid. The total area of the trapezoids is equal to TSi in
Equation 3
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Fig. 8 Fit and predictions obtained on a single realization of data in the Sln1 scheme. Black and red points (connected by lines of the same color)
refer to data points which were used for parameter estimation and validation, respectively. In this example, all doses of Sln1 data and the data on
the downstream species (protein, mRNA and internal glycerol) were used for parameter estimation. The magenta lines show the profiles obtained
(both fit and prediction) by using the true model for the parameter estimation. The orange lines belong to the profiles obtained by the simplified
model structure. All concentrations are given in percentages. The top three rows are for the Hog1PP data. The titles for each graph show the dose
and the cell type related to the experiment in which the Hog1PP data was collected. The last row of graphs give the concentration ratios for the
downstream species. The associated data was collected in a single experiment with WT cells following a 0.5 M. NaCl shock
examples. We should also mention that the term ’predic-
tion’ always refers to predictions on validation datasets,
throughout the text. Finally, we present our results on
both percentage error (PE) and model separation (TS)
using a box plot representation. With this representation,
each box plot shows the distribution of the associated
measure across the 100 different noise realizations. For
example, in the case of percentage error, the median of
this distribution gives an idea on how high the prediction
errors are in general. In addition, the box plots show also
the outliers with relatively high prediction errors by the
red points outside the boxes.
When only data from the Sln1 branch active deletion
mutant (Sln1 data) is used for parameter estimation, vali-
dation using the Sho1 branch active deletion mutant data
(Sho1 data) can be very misleading. This is because mod-
els trained by using Sln1 data results in bad predictions on
the Sho1 data. On the other hand, the same models can
achieve reasonable predictions on theWT data (See Fig. 8
for an example). This can be seen from the distribution of
the percentage prediction errors represented by box plots
for each validation set in Fig. 9a and b.
Existence of realizations with very high prediction
errors in box plots with lowmedians shows that extremely
bad predictions can occur even when the median pre-
diction error is not very high. Examples of this can be
observed also in the Sho1 scheme shown in Fig. 9c and d.
Indeed, the models trained by using only the Sho1 data
can lead to extremely high prediction errors both on Sln1
andWT data. This can be seen from the existence of real-
izations with a percentage prediction error above 30% and
15%, respectively. On the other hand, models trained by
using only the WT data perform well in predicting the
Sln1 data but not the Sho1 data (maximum of medians =
1.11% vs 4.20% in Fig. 9e and f). However, they are still
better than those obtained by the models trained by the
Sln1 data (maximum of medians = 4.20% vs 8.85% in
Fig. 9f and a).
As a summary of the observations on the predictive
power, we can say two things. Firstly, models trained by
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Fig. 9 Percentage prediction errors (PE) of the true model structure in scenario 1. Each box plot shows the distribution of PE over 100 different
realizations of the data. The red dots indicate the outliers which lie outside approximately 99.3% coverage if the data is normally distributed. They
indicate realizations with relatively higher PE. Blue, green and black boxes refer to Sln1, Sho1, and WT schemes. Each row in the figure corresponds
to a single scheme. The labels on the x-axis show the specific dose and the cell type of the data on which the validation was performed. The labels
indicate also the medians of the PE distribution summarized visually by the box plots. In each graph, the ten realizations with the highest PE are
located above the black dashed line. The region above this line is compressed for visual ease. a PE obtained on Sho1 validation subsets in the Sln1
scheme. b PE obtained on WT validation subsets in the Sln1 scheme. c PE obtained on Sln1 validation subsets in the Sho1 scheme. d PE obtained on
WT validation subsets in the Sho1 scheme. e PE obtained on Sln1 validation subsets in the WT scheme. f PE obtained on Sho1 validation subsets in
the WT scheme
using only the data from one of the deletion mutants
is poor in predicting the data from the other. Secondly,
models trained by using the data from the WT cell can
predict the data from one of the deletion mutants better
than the other one. The poor predictions might easily lead
to misleading decisions on model validation. True model
structuresmight fail to be validated due to weak predictive
power of some partitioning schemes. To study the rea-
sons leading to weak predictive power we investigated the
parameter estimation quality.
We measured the parameter estimation quality by using
the normalized bias of each parameter. The median of this
measure across all noise realizations shows how well the
parameter was estimated in general in a certain scheme.
In Fig. 10b, we see that the parameters related to the
complex formation of Sho1 and Pbs2 proteins and this
complex’ phosphorylation, p8 and p9, were predicted with
very high bias in the Sln1 scheme. (see the yellow region
in Fig. 1). This means that when the Sln1 data is used
for model training, we estimate the Sho1 branch param-
eters with a very high uncertainty with a median bias of
31% and 33%, respectively. The same reasoning is valid
also for the estimation of two of the parameters related
to the phosphorylation of the Pbs2 protein, p4 and p5.
The median bias for these parameters (see the gray region
in Fig. 1) were found to be 17% and 14%, respectively
(see Fig. 10a). There is an interesting difference between
the estimation quality of the parameters in the two dif-
ferent branches, though. We could decrease the bias of
the Sln1 branch parameters considerably when we used
the WT data for training the model. However, the level
of bias in the Sho1 branch parameters was still relatively
high in the WT scheme compared to the Sho1 scheme.
Similarly, the identifiability analysis (see Fig. 10c) shows
that training the model on the WT data results in sim-
ilar standard deviations in the Sln1 branch parameters
when compared to the standard deviations obtained in
the Sln1 scheme. However, the standard deviations of
the Sho1 branch parameters are much lower in the Sho1
scheme compared to those obtained in the WT scheme
(see Fig. 10d) which suggests improved identifiability in
the Sho1 scheme. Therefore, the Sln1 data could be pre-
dicted well in the WT scheme whereas the prediction of
the Sho1 data was still problematic. As a further inves-
tigation on the system dynamics, we tuned one of the
branch parameters each time within a range limited by the
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Fig. 10 Normalized bias and standard deviation of branch parameters. Bar graphs show the median of the normalized bias and standard deviation
of parameters across all noise realizations. Only some of the branch parameters are shown in the figure. Parameters p4-p5-p6 play a role in the Sln1
branch and parameters p8-p9-p10 are in the Sho1 branch. Blue, green and black refers to the Sln1, Sho1 and WT schemes respectively. aMedian of
normalized bias in Sln1 branch parameters. bMedian of normalized bias in Sho1 branch parameters. cMedian of normalized standard deviation in
Sln1 branch parameters. dMedian of normalized standard deviation in Sho1 branch parameters
minimum and maximum of their estimated values. This
allowed us to confirm the deteriorating effect of biased
branch parameters on the predictions (data not shown).
The asymmetrical behaviour of the predictive power
(that is, the WT and the Sln1 schemes were good in
predicting Sln1 and WT validation data, respectively but
none of them could achieve good predictions on the Sho1
validation dataset) stems from an underlying biological
property which is the inequality of the two phosphoryla-
tion branches in the model. Although the two branches
(Fig. 1) act redundantly for the ultimate goal of Hog1 pro-
tein phosphorylation, the fluxes in each branch are not
equal. As also mentioned in [25], the Sho1 branch active
deletion mutant produces less output in terms of phos-
phorylated Hog1 protein. This biological fact manifests
itself also in the data. The WT data is characterized more
by the activity in the Sln1 activation branch rather than
the Sho1 branch. In other words, the Hog1PP levels in
the WT cell are affected more by the changes in the Sln1
branch parameters than by the changes in the Sho1 branch
parameters. Therefore, theWT data can substitute for the
Sln1 data for training the models. However, the cost of
excluding the Sho1 data from the training set is higher due
to the asymmetry we mentioned above. The Sho1 branch
parameters are weakly identifiable when the Sho1 data is
not used for parameter estimation. This asymmetry in the
information content of the data is clearly the output of
the pathway machinery. This machinery is summarized
into a model with a model structure and parameter val-
ues. Therefore, the decisions of model validation using
a hold-out strategy is dependent on the underlying bio-
logical properties (the asymmetrical branch structure in
this particular example) and reflections of these proper-
ties in the model parameters (parameter values that allow
less flux in one of the branches). The data partitioning
task, hence, proves to be a difficult one since the prior
knowledge about the underlying biology would never be
complete.
Another important observation is the NaCl dose depen-
dency of the predictive power using the Sho1 data. The
predictive power using Sho1 data was especially lower in
the lowest two doses compared to the higher doses as can
be seen in Fig. 9a and f (maximum of the medians 8.85%
vs. 4.65% in the Sln1 scheme and 4.20% vs. 1.52% in the
WT scheme).
The asymmetry in the contribution of the Sln1 and the
Sho1 branches to the phosphorylation of the Hog1 pro-
tein also has consequences for model selection. Figure 11
shows the number of wrong decisions given on each vali-
dation subset in each of these three partitioning schemes.
We see that in a high number of realizations, the sim-
plified model structure was selected over the true model
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Fig. 11 Number of wrong decisions in scenario 1. Bars show the number of realizations in which the simplified model gave lower residuals than the
true model structure and therefore, was wrongly selected over the true model structure. Blue, green and black bars refer to Sln1, Sho1, and WT
schemes. Each row in the figure corresponds to a single scheme. The labels on the x-axis show the specific dose and the cell type of the data on
which the validation was performed. a Number of wrong decisions using Sho1 validation subsets in the Sln1 scheme. b Number of wrong decisions
using WT validation subsets in the Sln1 scheme. c Number of wrong decisions using Sln1 validation subsets in the Sho1 scheme. d Number of
wrong decisions using WT validation subsets in the Sho1 scheme. e Number of wrong decisions using Sln1 validation subsets in the WT scheme. f
Number of wrong decisions using Sho1 validation subsets in the WT scheme
structure when the Sho1 data was used for validation
(Fig. 11a and f). On the other hand, using only the Sho1
data for training also resulted in an increased number of
wrong decisions on the Sln1 data compared to the WT
scheme (minimum number of wrong decisions 12 vs. 1 in
Fig. 11c and e).
In this section, we focused on partitioning schemes
which use the data from only one cell type for parameter
estimation. Our results show the importance of having a
variety of different validation sets. This is because deci-
sions of model validation and selection vary considerably
depending on the experimental conditions of different
validation sets due to unknown values of the underlying
parameters.
Scenario 2: partitioning of data in different doses
In the second scenario, where we use different doses as
training sets, we see a change of predictive power on Sho1
validation data (see Fig. 12b and e) . When the lowest dose
data from all three cell types are used for training, the
predictive power on the Sho1 data decreases with increas-
ing dose (median 1.11% vs. 3.16% on 0.1 M. and 0.8 M.
dose levels, shown in Fig. 12b). Also, when the highest
dose scheme is used, the predictive power increases with
increasing dose (median 2.59% vs. 1.11% on 0.07 M. and
0.6 M. dose levels, shown in Fig. 12e).
These results showed us that predictive power becomes
lower with increasing distances between the training and
the validation sets, where the distance is measured in
terms of the dose of the triggering chemical. This means
that the risk of invalidating the true model structure
increases when the validation set is too distant from the
training set. However, the limits between which the model
parameters stay applicable depend very much also on the
cell type as we have observed. The predictive power on
the Sho1 data deteriorated more rapidly compared to the
other cell types. These observations helped us to iden-
tify a serious pitfall of dose-response strategy: as long as
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Fig. 12 Percentage prediction errors (PE) of the true model structure in scenario 2. Each box plot shows the distribution of PE over 100 different
realizations of the data. The red dots indicate the outliers which lie outside approximately 99.3% coverage if the data is normally distributed. Gray
and yellow boxes refer to the lowest and the highest dose schemes, respectively. Each row in the figure corresponds to a single scheme. The labels
on the x-axis show the specific dose and the cell type of the data on which the validation was performed. The labels indicate also the medians of the
PE distribution summarized visually by the box plots. In each graph, the ten realizations with the highest PE are located above the black dashed line.
The region above this line is compressed for visual ease. a PE obtained on Sln1 validation subsets in the lowest dose scheme. b PE obtained on Sho1
validation subsets in the lowest dose scheme. c PE obtained on WT validation subsets in the lowest dose scheme. d PE obtained on Sln1 validation
subsets in the highest dose scheme. e PE obtained on Sho1 validation subsets in the highest dose scheme. f PE obtained on WT validation subsets
in the highest dose scheme
we do not have realistic prior information on the limits
for which we expect the estimated values of the model
parameters to be applicable, we face the risk of inval-
idating a true model structure by over-challenging the
model. Unfortunately, determination of the limits is not
possible beforehand since it depends on the underly-
ing biological properties which will never be completely
known.
When it comes to model selection, we face a different
challenge. Figure 13 shows the number of realizations in
which the simplified model structure was selected over
the true model structure. For example, the lowest dose
scheme results in 22 wrong decisions whereas the highest
dose scheme results in only 2 wrong decisions when the
0.1 M. Sln1 dataset is used as validation dataset as can be
seen in the upper left hand side corner of Fig. 13. Here,
only the results on validation sets that can be used in both
schemes are shown because our focus is on comparing
the performance of two different schemes on shared val-
idation sets. The most important observation from the
figure is that the number of wrong decisions by the low-
est scheme is higher on the 0.1 M. - 0.2 M. Sln1 and WT
data compared to the highest dose scheme. The num-
ber of wrong decisions by the lowest scheme is very high
(22 and 30 on the Sln1 and WT validation data, respec-
tively) especially on the 0.1 M. dose which is very close to
the 0.07 M. dose where the models were trained. In addi-
tion, we see that the highest scheme gives a slightly higher
number of wrong decisions compared to the lowest dose
scheme on the 0.6 M. Sln1 and WT data. These obser-
vations suggest that model selection is problematic when
the training and validation sets are too close to each other.
We looked further at the model separation between the
true and the simplified models (see Fig. 14) to investigate
the separation between the twomodel structures in higher
resolution.
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Fig. 13 Number of wrong decisions in scenario 2. Bars show the number of realizations in which the simplified model gave lower residuals than the
true model structure and therefore, was wrongly selected over the true model structure. Gray and yellow bars refer to the lowest and the highest
dose schemes. The labels on the x-axis show the specific dose and the cell type of the data on which the validation was performed. Here, only the
twelve validation subsets which could be used in both the lowest and the highest schemes are shown
In cases where the differences between the number of
wrong decisions is too low for a meaningful comparison,
the model separation, TS is more informative. Figure 14
shows the percentage of the realizations in which one spe-
cific scheme resulted in better model separation than the
other scheme. The percentages are based on the num-
ber of realizations in which a correct decision was made
by using both the lowest and the highest dose schemes.
For example, we know that both schemes result in a cor-
rect decision in 77 realizations of the Sln1 data at 0.1 M.
NaCl shock (data not shown). The first pie chart in Fig. 14
shows that in 99% of these 77 realizations, the highest
dose scheme resulted in better separation between the
two model structures than the lowest dose scheme. As
can be seen from this figure, model separation obtained
by the highest dose scheme is higher than that obtained
by the lowest dose scheme in almost all realizations of
0.1 M. - 0.2 M. Sln1 and WT data. At 0.6 M. dose, the
situation is reverse and the lowest scheme provides a bet-
ter separation of the two model structures, in most of
the realizations of all three cell types. These findings sup-
port the observation we made from the number of wrong
decisions: model selection becomes problematic with too
close training and validation sets. This is mainly because
the simplified model might also predict well in the close
proximity of the training dose (See Additional file 1: Figure
S1). However, it will perform worse than the true model
structure as the training and validation sets become more
distant from each other. However, too much distance can
also pose a problem for model selection due to increased
uncertainty in the predictive power. Uncertainty in the
predictions shows that different noise realizations can
either give very good or very bad predictions. High levels
of uncertainty reveals itself in the wide box plots of espe-
cially Sho1 validation data in Fig. 12b, 12e and Additional
file 1: Figure S1, showing a wide dispersion of predictive
power across different noise realizations. In these regions
where the uncertainty is high, it becomes more difficult to
anticipate the predictive powers of the true and the sim-
plified model structures on a single noise realization. This
hampers also model selection. Using Sho1 validation data
results in such a situation where uncertainty is very high
at certain doses. This is why the trends in model selection
that we have presented in this section cannot be observed
on the Sho1 validation data as sharply as on the other cell
types.
We can understand the risks associated with high uncer-
tainty in a hold-out strategy, if we remember that in a sin-
gle real experiment we have only one realization of noise.
The outcomes of both model validation and selection
depend highly on the specific noise realization in the data
but we have only one realization available. This means that
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Fig. 14 Comparison of model separation by the two schemes. Each pie chart shows the percentage of correct decisions, where the model
separation achieved by a certain scheme is better than the other scheme. The labels on the x-axis show the specific dose and the cell type of the
data on which the validation was performed. Gray and yellow colors in the charts refer to the lowest and the highest dose schemes. Here, only the
twelve validation subsets which could be used in both the lowest and the highest schemes are shown. For example, when the 0.1 M. Sln1 data was
used for validation, in 99% of the realizations in which a correct decision was given by both schemes, higher distance between the predictions of
the true and the simplified model structures was achieved in the highest dose scheme than the lowest dose scheme
it is highly probable that we end up in wrong decisions
just due to experimental noise. Therefore, we need parti-
tioning schemes that minimize the effect of idiosyncratic
noise realisations and lead to similar decisions for all of
them. The stratified random cross validation scheme is
promising in this sense as we will explain in the following
section.
Introducing variation in the training and the test data
In the previous sections, we showed the pitfalls that we
might come across if we use single doses or single cell
types as validation data. Therefore, we stress the impor-
tance of consensus results obtained from a collection of
different validation sets. In this section, we take it one
step further and introduce variation of experimental con-
ditions also in the training data. We do it in three different
ways as described by the adapted scenarios and the strat-
ified cross validation scheme in the Methods section.
First, we include two different cell types in the training
data, namely in the Sln1/Sho1, Sln1/WT and Sho1/WT
schemes. Second, we include four different doses from
each cell type in the training data, namely in the low
doses and the high doses schemes. These are examples
of hold-out validation strategies just like the previous two
scenarios. However, unlike those, the training and the vali-
dation sets include a variety of different cell types or doses.
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The third way is not an example of a hold-out strategy. It
is the stratified random cross-validation (SRCV) scheme
about which we have given the details in the Methods
section. With this approach we can introduce variation in
the training and validation sets in terms of both cell types
and doses at the same time.
Firstly, we compare the schemes in which the train-
ing set includes different cell types. The most important
observation regarding these three schemes is the low pre-
dictive power in the Sln1/WT scheme as can be seen in
Fig. 15a. This shows that when the models are trained
without using the Sho1 data, validating them on Sho1 data
is risky. On the contrary, when the Sln1 data is missing
in the training set, we do not observe such low predic-
tive power. The reasons for this can be traced back to the
asymmetrical branch structure that we explained in detail
in the Scenario 1 section. Therefore, we do not discuss
those here again.
In addition to the risks associated with model valida-
tion, the Sln1/WT scheme performes poorly also inmodel
selection with 16 wrong decisions. Therefore, we conclude
that the Sln1/WT scheme is not a good scheme for model
validation and selection whereas the Sln1/Sho1 and the
Sho1/WT are sensible partitioning schemes. The SRCV
scheme results in prediction errors that are comparable
with the sensible partitioning schemes (Fig. 15a). Further-
more, it results in no wrong decisions and it gives the
highest model separation compared to the Sln1/Sho1 and
Sho1/WT schemes which also result in all correct deci-
sions (Fig. 15b). In addition to this, the predictive power
of such a scheme is less dependent on the noise realiza-
tion compared to the other schemes as can be seen from
the smaller box plots in Fig. 15a. This indicates the low
amount of uncertainty in the predictions.
When only doses were allowed to vary in the training
set as in the case of the low doses and the high doses
scheme, there was no significant difference in the predic-
tive powers of the two schemes (Fig. 15c). This revealed
that none of the schemes posed more risk of invalidating
the true model structure compared to the other scheme.
However, there was a large difference in the model sep-
aration achieved by the two schemes (median = 16.9
Fig. 15 Percentage prediction errors (PE) and model separation (TS) in the adapted scenarios. Each box plot shows the distribution of PE or TS
over 100 different realizations of the data obtained in a single scheme. The red dots indicate the outliers which lie outside approximately 99.3%
coverage if the data is normally distributed. Black, blue and green boxes in the first row of graphs refer to the Sln1/Sho1, Sln1/WT and Sho1/WT
schemes. Cyan boxes refer to the stratified cross-validation (SRCV) schemes. Gray and yellow boxes in the second row refer to the low doses and
high doses schemes. The labels on the x-axis indicate the medians of the PE or TS distribution summarized visually by the box plots. The axis labels
in the TS graphs show also the number of wrong decisions given in each scheme. In each graph, ten realizations with the highest PE or TS are
located above the black dashed line. The region above this line is compressed for visual ease. a PE obtained in adapted cell type scenario. b TS
obtained in adapted cell type scenario. c PE obtained in adapted dose scenario. d TS obtained in adapted dose scenario
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vs. 5.06 in the low and high doses schemes respectively,
shown in Fig. 15d). This shows that the high doses scheme
is unsuitable for model selection. A simulation show-
ing weak model separation according to the highest dose
scheme can be seen in Additional file 1: Figure S2. The
SRCV scheme performed better than the unsuitable hold-
out partitioning scheme for model selection (median 
TS = 8.18) and the predictive power was in the range of
the two hold-out partitioning schemes (Fig. 15c).
The observations explained above can also be antici-
pated from the identifiability levels. The standard devi-
ations of parameters at all three runs of the SRCV
scheme were comparable to those obtained in the sensible
hold-out partitioning schemes for model validation (see
Additional file 1: Figure S3) and were never higher than
those obtained in the unsuitable schemes.
These results indicated that a stratified CV scheme
is favorable for both model validation and selection. In
most of the comparisons, it achieves predictive power and
model separation as high as the optimal hold-out parti-
tioning scheme. In addition, it leads to lower uncertainty
which means that the outcomes of model validation and
selection depend less on the specific noise realization.
More importantly, it never performs worse than unsuit-
able hold-out partitioning schemes. The importance of
this last statement lies in the fact that finding a sensible
hold-out partitioning scheme can never be guaranteed. It
depends highly on the biology and therefore, on the model
structure and the model parameters most of which are
typically unknown prior to modeling. Therefore, there are
no rules that can be set beforehand to make the finding of
sensible partitioning schemes certain. Those factorsmight
hinder us from opting for a sensible scheme. However,
SRCV offers a judicious and reliable partitioning scheme
for which no biological knowledge is required. Its good
performance relies on two properties. Firstly, it is iterative
whichmeans that it allows each piece of data to contribute
as both training and validation datasets in an iterative
manner and summarizes the results as the average of
different iterations. Secondly it offers random stratified
partitioning, so it allows fair partitioning of the data while
it prevents from certain cell types or doses dominating
the training data. Therefore, issues like parameter estima-
tion and model validation/selection are not biased in a
certain direction as an artifact of an underlying biological
property of the system, in contrast to the hold-out vali-
dation schemes we have extensively investigated with this
study. In addition, we achieve this by using a CV scheme
with 3 folds and no repeats and hence, the computational
time increases only three times compared to the hold-out
schemes.
On the other hand, our additional simulations with
two more complex models revealed that a prerequisite
for model selection based on predictive power has to
be mentioned. The first more complex model included
one additional parameter (Hog1 dependent Fps1 degrada-
tion) whereas the second model included three additional
parameters (Hog1 dependent Fps1 degradation, Fps1 pro-
duction and protein dependent Fps1 degradation). We
have found out that the additional parameters were esti-
mated very close to 0. Median of the parameters changed
between 0.8 × 10−5 and 0.4 × 10−7 in all of the schemes.
This means that both of the complex models boiled down
to the true model structure. Therefore, the differences in
the prediction errors obtained with the complex and the
true model structures were very small. For example, the
difference in the prediction errors of the true and the
complexmodel structure was, in average 2.03% of the pre-
diction error of the true model structure obtained with
the Sln1/Sho1 scheme. However, this value was 146% in
our simulations with the simplified model structure. At
this level of extreme similarity between the model struc-
tures, model selection based on tiny differences between
the predictive powers of the models leads to random con-
clusions that are heavily dependent on the specific noise
realization in the data. Instead in such situations, investi-
gating the estimated values of the additional parameters
gives clue if a more complex model is needed or not.
From this we derive the following important conclusion
regarding the scalability of our approach. The guidelines
we present in our manuscript are aimed for more reliable
decision making in model selection when the selection is
made based on the predictive powers of the models. In
cases where such model selection is not applicable, our
guidelines are obviously not applicable either.
Conclusions
Our results showed that the final decisions on model vali-
dation and selection can differ significantly when different
hold-out partitioning schemes are employed. The selec-
tion of a sensible hold-out partitioning scheme that will
help us to make reliable decisions depends on the biol-
ogy. A good biological knowledge on the system and,
hence, prior information on the structure and the true
parameter values of the model are essential. Unfortu-
nately, this is not possible in many instances. This turns
the problem of finding a sensible partitioning scheme for
model validation and selection into a Catch 22 problem.
When the determination of a sensible partitioning scheme
fails, we face the risk of invalidating true model struc-
tures or of failing to select the true model structure over
the other alternatives. Examples of the first situation are
very difficult to find in the literature, though, because,
only successful validation examples are usually presented,
leading to a ‘verification bias’. Furthermore, partitioning
schemes that are sensible for model selection are not nec-
essarily suitable for model validation. Datasets from very
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similar experimental conditions have only weak model
selection capability whereas datasets from very diverse
experimental conditions are not appropriate for model
selection either due to high uncertainty in the predic-
tions. However, using a proper cross-validation approach
such as stratified random cross-validation can help us to
overcome these problems while being independent of any
prior biological knowledge.
With the SRCV approach, we can partition the data
randomly into training and validation sets iteratively and
arrive at consensus decisions by averaging over all dif-
ferent validation datasets. SRCV performs at least as
well as sensible hold-out partitioning schemes for both
model validation and selection. On top of that, this comes
without the risk of opting for an incorrect partitioning
scheme which would lead us to biased conclusions. Fur-
thermore, the decisions given within a SRCV scheme are
less affected by the specific realization of the experimen-
tal noise. Due to all these reasons that we mention, SRCV
proves to be a judicious, unbiased and promising alterna-
tive to the hold-out validation strategy for the validation
and selection of ODE based models.
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